Why Your Serialized Production Traceability Records May Not Be as Defensible as You Think

The week before an FDA inspection, a quality team at a medical device company is usually not reviewing production data. They're assembling it.

Someone is tracking down signatures on paper travelers that got filed months ago without being completed, while someone else cross-references handwritten logs against batch records to confirm the timestamps line up. A third person is reconciling what the MES transaction history shows with what the paper records say took place on the floor.

The execution itself probably went fine. Operators did the work correctly. Materials were right. In-process checks happened at each station.

The gap shows up in the documentation layer. The traceability record was assembled separately from the work, rather than produced by it.

When operators document what they've done after completing each step, rather than treating documentation as a condition for advancing production, the resulting record is built from what people reported they did, without any system verification that it happened. In regulated manufacturing environments where auditors are specifically trained to look for contemporaneous capture, that architectural gap can translate directly into a Form 483 observation, even when the underlying work was executed correctly.

There's a different architecture that changes what your traceability records can prove. It treats the record as an output of controlled execution, not a reconstruction of it.

This post walks through what that approach looks like mechanically, why it satisfies the contemporaneous record requirements of FDA QMSR, AS9100, and similar regulated manufacturing standards, and how manufacturers in medical device, aerospace, and electronics are getting there without an 18-month MES deployment.

The standard for a defensible traceability record in regulated manufacturing is more precise than it might appear from the outside. Regulators don't just want a complete record. They want a contemporaneous one.

In FDA and ISO 13485 contexts, contemporaneous means the record was created at the time the event occurred. Not hours later, not at the end of the shift, not the night before the inspection. AS9100 sets the same expectation for aerospace, requiring cradle-to-grave documentation traceable to the specific unit, with a production history that reflects the actual sequence of events.

Most digital traceability systems technically meet this bar on paper. The operator scans the unit, fills in the fields, clicks complete. The system creates a record. But the sequence is equally important. When data entry happens after the work step is complete, the timestamp on the record reflects when data was entered, not when the work happened.

FDA investigators trained in 21 CFR Part 820 know to look for this. Timestamp inconsistencies, blocks of records entered at the end of a shift, data that clusters at station handoffs rather than at execution moments: these are the patterns that distinguish a contemporaneous record from a retroactive one.

At scale, in high-mix, multi-station environments, this gap compounds. A step completed at station three might not be documented until an operator reaches station six, when they have a moment to catch up on their batch record. A quality inspection that "happened" on Tuesday afternoon might get recorded Wednesday morning. By the time the unit reaches final inspection, the record may reflect a different execution sequence than the one that occurred.

The record is complete, but it may not be accurate.

The organizational pattern that creates this outcome is fairly consistent. Across regulated manufacturers, traceability tends to be treated as a quality function that runs alongside production, rather than a property of the production process itself.

The quality team owns the record.

The production team owns the work.

When these are managed separately and the documentation process is structurally decoupled from the execution process, the gap is built into the design, not a failure of execution.

For medical device manufacturers, the stakes are concrete. Documentation deficiencies consistently appear among the most common FDA Form 483 inspection observations, and paper-based or incomplete DHR processes create structural vulnerability that follows the operation into every inspection.

The same goes for aerospace and defense manufacturers. AS9100 auditors expect to be able to reconstruct the exact sequence of production events for any serialized unit. When records are assembled after the fact, they may satisfy the completeness check, but will likely struggle under close examination of the event sequence.

In many traceability systems, data collection is an additional step that follows the work. The operator finishes a stage, then records it. Or they finish a station, pull up the batch record, and enter what they observed after the fact. The guidance and the record live in separate workflows.

Execution-enforced traceability ensures that data capture is built into each step of a guided work instruction as a required condition for advancing to the next one. The scan has to happen, the measurement has to be recorded, and the e-signature has to be completed before the quality gate closes. The operator can't skip these steps; the system won't allow it.

What this produces is a record that builds itself throughout the execution process. By the time a unit reaches end-of-line, the as-built record already exists. Every required data point was captured, every sign-off was logged at the moment the step occurred. There's no assembly step required after the fact because the assembly happened at each station.

The mechanism is granular by design. A digital work instruction with an embedded scan step captures the component serial number or lot ID when the operator physically scans it, linking that material to the unit being built automatically.

A torque tool connected to the production floor records the torque value when the fastener is driven and associates it with the unit's serial number. An environmental sensor logs the temperature or humidity reading during assembly, without operator intervention.

In audit conditions, the difference in what each approach can demonstrate makes a huge difference.

From a documentation-first system, the answer to "how do you know this step was completed?" is that the operator recorded it. From an execution-enforced system, the answer is that the system required it before production could advance.

Auditors who work regularly in FDA or AS9100 environments understand that distinction, and so do defense contractors preparing for CMMC certification.

Human sign-off remains an integral part of this model. Even with automated measurement capture and IoT-connected devices, qualified personnel are responsible for reviewing exceptions, verifying process completion at quality gates, and signing off on the record. What changes is when that review happens.

Qualified personnel review at the point of work with current data visible. The sign-off happens when the evidence is fresh. It's quality oversight woven into the work, applied as the work happens.

Defensible traceability in serialized production environments typically comes from three mechanisms working together, each addressing a different layer of the enforcement problem the previous section described.

Digital work instructions with embedded data capture make the record a required output of each step.

IoT and edge connectivity automate measurement recording at the points where operator data entry carries the most risk.

Serialized genealogy assembles the as-built record in real time as each step closes.

Each mechanism is necessary; none is sufficient alone.Work instructions without edge connectivity leave critical measurement data dependent on operator entry at exactly the steps where error risk is highest. Edge connectivity without serialized genealogy captures data without reliably binding it to the unit's production history.

When these three work together, the record that ends up in front of an auditor was assembled by the production process itself rather than constructed from it.

Digital work instructions with embedded data capture

A digital work instruction adds a step to the existing workflow. An embedded data capture step changes the workflow's structure.

When a scan step is required before a digital work instruction can advance to the next station, the operator's completion of that step produces a record, not as a side effect, but as the mechanism that allows the work to continue. The instruction won't proceed without the scan. A component isn't marked as installed until its serial number is captured. The quality gate won't close until the required signature is entered.

What this creates, over the course of a multi-station build, is a traceable sequence that reflects the actual execution order. Each required step creates its own timestamp. Each scan links the scanned material to the unit being built, writing the genealogy record automatically without a separate data-entry step. By the time the unit reaches final inspection, the as-built record has been assembling itself since the first station.

Smith+Nephew built its eDHR production lines on this architecture and achieved zero documentation non-conformances, alongside sterilization chamber utilization improvements. When compliance is a condition of each step, the record doesn't need to be enforced separately.

From the operator's perspective, the enforcement mechanism makes the right behavior the default. Completing the required scan or entering the required measurement isn't additional work; it's how the work instruction advances. The system structures the work so that compliance and completion are the same thing.

IoT and edge connectivity for automated measurement recording

At the most consequential measurement steps in a production process (torque, weight, dimensional inspection, environmental parameters), the operator data-entry step is where the evidentiary record is most vulnerable.

A torque value entered by hand is accurate if the operator read the wrench correctly, recorded the right number, and entered it at the right moment. An automated torque reading pushed from a calibrated connected tool to the serialized unit record involves no such judgment. The device's calibration record, the timestamp, and the reading all come from the same source, and auditors understand the difference in what each kind of record can support.

IoT-connected production equipment removes the data-entry step entirely at these points. Torque tools, scales, environmental sensors, and vision systems can push readings directly to the production record at the moment of measurement, linking the value to the unit's serial number automatically. There's no separate recording step, no opportunity for transcription error, and no gap between when the measurement was taken and when it appears in the record.

This connectivity is also what enables real-time enforcement of tolerances. When an edge-connected device captures a value that falls outside specification, the workflow can be configured to flag it before the unit moves to the next station. The defect is caught at the station where it was created rather than traveling downstream. In aerospace and medical device production, where the cost of a non-conformance that reaches end-of-line can be substantial, detection at the point of work changes where in the process problems get resolved.

Tulip's edge device ecosystem, including Edge IO and Machine Kit, connects to existing production equipment, which matters in environments where replacing tools for compliance purposes isn't feasible. The data the equipment already generates gets captured in the traceability record without operators having to move it there manually.

Serialized genealogy that assembles in real time

The practical test for a traceability record's value often comes not during production, but at the moment of batch release or during a nonconformance investigation.

At batch release, the question is whether the DHR is complete, accurate, and ready for QA review. In documentation-first systems, that question triggers a separate record assembly process. In systems where the genealogy has been building alongside the work, the record is already there.

Tulip's Tables API creates a live, serialized genealogy record for each unit, linking every captured data point to the unit's identifier as the work proceeds. That includes operator actions, machine readings, inspection results, material lot IDs, and e-signatures. By end-of-line, the unit's complete production record contains every step completed, every measurement taken, every inspection passed, and every deviation flagged and dispositioned.

Both forward and backward traceability queries are immediately answerable from this record. Which units were built using material from this specific supplier lot? What went into this particular unit in terms of material, process parameters, operator, and equipment ID? In a recall investigation or a customer nonconformance claim, the speed of that answer matters.

The business outcome Avon Technologies reported after implementing Tulip reflects what real-time genealogy enables at batch release. Product release time went from 2 to 3 weeks down to approximately one hour. The DHR closed itself as the build progressed rather than being assembled once the build was complete.

Genealogy data in Tulip also connects to ERP, MES, and PLM systems via open API. Serial numbers, lot IDs, and production events can flow to enterprise systems without duplicate data entry. The execution layer produces the record; the enterprise systems consume it.

Every compliance framework that governs serialized manufacturing, including FDA QMSR, ISO 13485, AS9100, and GxP, requires traceability records to be contemporaneous. That word appears in regulatory guidance because it was chosen carefully. Contemporaneous means created at the time the event occurred, not assembled to account for what occurred.

In our experience, quality teams are often confident that their traceability records are complete. Fewer are confident the timestamps would survive a hard look.

Execution-enforced traceability satisfies this standard most directly. Every timestamp in the record corresponds to an event the system required, not an entry made afterward.

FDA QMSR and ISO 13485: The FDA's Quality Management System Regulation, which went into effect in February 2026, aligns U.S. medical device requirements directly with ISO 13485:2016. Manufacturers must maintain a Device History Record for each unit documenting materials, manufacturing dates, acceptance activities, labeling, and distribution. Records must be legible, contemporaneous, and traceable to the specific unit. Manufacturers still running paper DHR processes face heightened compliance scrutiny under the updated framework.

AS9100 for aerospace: AS9100 Rev D requires serial numbers, part numbers, approved suppliers, quality checkpoints, and nonconformance dispositions for every serialized unit, audit-ready at all times. The standard's expectation of cradle-to-grave documentation is most cleanly satisfied by a system that builds the record as the unit moves through the production sequence, rather than reconstructing it afterward.

CMMC for defense contractors: CMMC 2.0 Level 2 third-party certification is mandatory by November 2026 for contractors handling Controlled Unclassified Information, with preparation typically taking 6 to 12 months. The production systems manufacturers select now, including the execution layer where traceability data is generated, need to meet the data governance and access control requirements of that framework. Tulip's FedRAMP Moderate equivalency addresses this directly.

GxP and 21 CFR Part 11: For medical device manufacturers, Tulip's platform is GxP-ready with immutable audit trail, electronic signature controls, and access management built into the architecture. Computer Software Assurance (CSA) support means risk-based validation aligned with FDA guidance, with validation scoped to each use case rather than site-wide for every change.

The compliance argument comes together most clearly in how QA review works when the record is already complete at end-of-line. One medical device manufacturer built a greenfield facility, then moved from empty production floor to a fully validated eDHR on Tulip in 9 months, covering MES, quality, inventory, and continuous improvement use cases. QA review time dropped by 93%, with 100% elimination of missing signatures. That outcome is what the Review by Exception model produces when every step in the production process was verified and captured. Quality review focuses on what deviated. Completeness is already guaranteed by the process.

The most common objection we hear from operations leaders who recognize the traceability problem isn't about whether a better approach exists. It's about whether their organization can realistically get there. The prevailing assumption, reinforced by years of traditional MES vendor conversations, is that fixing serialized traceability requires a comprehensive MES deployment, and that means 12 to 18 months before a single line is producing defensible records.

Traditional MES implementations require comprehensive deployment before most functionality is available, which is where that timeline comes from. Composable platforms start from a different point.

The deployment path looks like this: one line, one product family, one bounded use case. Digital work instructions with embedded scan and data capture steps, deployed to a single production station or work cell, with the serialized genealogy app connected. Validate the approach on that use case. Demonstrate the improvement in record completeness and audit readiness. Then expand.

The validation question for regulated manufacturers is usually where this conversation pauses. Tulip's CSA-aligned approach follows FDA's Computer Software Assurance guidance, with risk-based validation scoped to each use case rather than site-wide revalidation for every change. A new app for a new product family is validated as its own use case; it doesn't require re-validating the entire deployment. For manufacturers who have spent years managing the revalidation burden of legacy systems, that's a structural change in how compliance work gets distributed.

The medical device manufacturer mentioned in the previous section built a greenfield facility and moved from empty production floor to fully validated eDHR in 9 months, covering MES, quality, inventory, and CI use cases, with over $1 million in savings compared to a traditional MES implementation. That pace is possible when a composable deployment doesn't need to wait for a large-scale system to be fully configured before any lines go live.

Avon Technologies completed its MES migration using Tulip in 6 months, against an estimated 18-month timeline with a traditional approach. The migration was scoped to the specific traceability and execution use cases they needed first, and the system expanded from there.

On the IT integration side, Tulip's open API connects to existing ERP, MES, and PLM systems. Serial numbers, lot IDs, work orders, and engineering revisions flow between systems without duplicate data entry. The composable execution layer complements what's already in place. ERP and legacy MES weren't designed to manage guided work instructions, IoT data capture, and serialized genealogy at the operator level. That's the specific gap this layer fills.

A traceability record's value is tested most precisely in moments operations teams don't expect. An FDA investigator pulls a specific unit's DHR and asks about a particular timestamp. A nonconformance investigation turns on whether the right data was captured at station three. A recall's scope depends on how precisely you can identify which units were affected.

An execution-enforced approach produces records that can answer those questions from the production system itself, because the system required the answers before it allowed production to advance. Getting there typically doesn't require starting from zero or a platform-wide commitment.

Manufacturers who work through this often find that the traceability improvement compounds in ways they didn't fully anticipate. DHRs close on their own as production advances. Defect detection moves upstream to the station where the issue was created, caught before it reaches final inspection. These are audit benefits and operational ones, and they tend to accumulate over time.

If you're evaluating how to approach serialized production traceability in your operation, the Tulip team would be glad to walk through what the composable MES approach looks like for your specific use cases. Reach out here.